Please login to the form below
outcomes
This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.
BMS and Janssen’s antithrombotic granted FDA fast track designation
List added: “We are now focused on enrolling patients to these trials with urgency, bringing us one step closer to potentially improving outcomes in a wide range of patients with thrombotic
Latest news
-
Pfizer’s maternal RSV vaccine candidate backed by FDA advisory committee
Annaliesa Anderson, senior vice president and chief scientific officer, vaccine research and development at Pfizer, said: “We are encouraged by the outcome of [the] VRBPAC meeting as it is a critical
-
VMLY&R and KDog join forces in project to train abandoned dogs to become medical detection dogs
It’s a privilege to launch such a sustainable, symbiotic, and scalable solution that can change health outcomes for so many.”.
-
GSK’s RSV vaccine approved by FDA for older adults
risk of severe RSV outcomes.
-
GSK’s RSV vaccine candidate recommended by CHMP for older adults
risk of severe RSV outcomes.
-
Janssen’s Akeega receives EC approval for metastatic prostate cancer
Patients with mCRPC and homologous recombination repair (HRR) gene alterations, of which BRCA mutations are the most common, are more likely to have aggressive disease, poor outcomes and a shorter survival ... outcomes in mCRPC patients with or without
More from news
Approximately 14 fully matching, plus 2,094 partially matching documents found.
Latest Intelligence
-
Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
The Inequalities Tracker is part of the Quantis suite of tools, designed to improve patient outcomes by enabling your organisation to support the NHS in improving diagnostic and treatment pathways. ... Quantis utilises and cross-references five years of
-
How an AI algorithm might save your life
In the meantime, AI developers in healthcare have been working relentlessly to develop AI tools that can improve healthcare experiences and patient outcomes.
-
Working together to achieve better patient pathways
of care aspects including clinical trial outcomes, which clearly has a massive financial benefit. ... Their input has been pivotal in developing protocols that are resulting in transformative outcomes.
-
Improving outcomes for prostate cancer patients
Prostate cancer is the most common cancer in men across the United Kingdom, with approximately one in eight men being diagnosed with prostate cancer at some point in their life
-
Using the power of data to future-proof the clinical development industry
Sponsors can use these methods to accurately model safety and efficacy outcomes – reducing the overall number of patients needed and accelerating studies.
More from intelligence
Approximately 11 fully matching, plus 629 partially matching documents found.
Latest appointments
-
OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access
In a career covering more than 30 years, Chick offers an extensive background of experience in business development and leadership positions in the health economics and outcomes research fields, as well ... I look forward to leveraging the assets and
-
Hanover appoints Ian Dodge to its senior adviser panel
delivers better outcomes for patients and value for taxpayers.
-
Andy Black joins Lucid Group as non-executive chairman
some of the most challenging healthcare problems through an outcomes-led approach.
-
Christianna Gorin is appointed Health Practice Lead and Chief Strategy Officer, VMLY&R Health
We’re united in our commitment to improving health outcomes and living up to increasing consumer and HCP expectations.”.
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
Serap joins us at an exciting time for Ashfield Engage, as the demand for patient engagement programmes propels across the industry to support patients, improve adherence and achieve better outcomes,” said
More from appointments
Approximately 0 fully matching, plus 72 partially matching documents found.
Latest from PMHub
-
Survey launch: The future of HCP engagement impact
The study will build a comprehensive picture to help inform Pharma HCP engagement strategies and ultimately support better outcomes for all stakeholders. ... Share your experience/perspective to support depth of insight. An opportunity to reflect on
-
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
In this new publication, our oncology experts provide insights on the trends, challenges and opportunities for biopharmaceutical companies, including why an interdisciplinary approach is needed to improve outcomes in oncology. ... outcomes for cancer
-
Design-thinking. Iterating for continuous improvement.
This means creating products and services that have a measurable effect on patient outcomes. ... As the pharmaceutical industry evolves, design thinking will be critical in driving innovation and improving patient outcomes.
-
Eoin McAtamney announced as Managing Director of Ashfield Ireland
ssible outcomes, as well as the operational sensitivities in the current market.
-
Ashfield to host webinar on Patient Support Programmes on Tuesday 10 October
Pharma’s ambition is to deliver a truly differentiated service with measurable results and improved patient outcomes.
More from PMHub
Approximately 14 fully matching, plus 736 partially matching documents found.
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
